A radiobiological model for the relative biological effectiveness of high-dose-rate 252Cf brachytherapy

Radiation Research

Volumn 164, Issue 3, 2005, Pages 319-323

  Rivard, Mark J ^a   Melhus, Christopher S ^a   Zinkin, Heather D ^a   Stapleford, Liza J ^a   Evans, Krista E ^a   Wazer, David E ^a   Odlozilíková, Anna ^b  

^a TUFTS MEDICAL CENTER   (United States)

^b MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CALIFORNIUM 252;

ARTICLE; BIOLOGICAL MODEL; BRACHYTHERAPY; CELL KILLING; CELL SURVIVAL; DNA REPAIR; DNA STRAND BREAKAGE; GAMMA RADIATION; NEUTRON; PHOTON; PRIORITY JOURNAL; RADIATION DOSE; RADIOBIOLOGY; RUSSIAN FEDERATION; SURVIVAL RATE; TISSUE OXYGENATION; X RAY;

ANIMALS; BODY BURDEN; BRACHYTHERAPY; CALIFORNIUM; CELL SURVIVAL; COMPUTER SIMULATION; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; RADIOBIOLOGY; RADIOMETRY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, COMPUTER-ASSISTED; RELATIVE BIOLOGICAL EFFECTIVENESS; TREATMENT OUTCOME;

EID: 24144475942     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR3416.1     Document Type: Article

References (23)

1. C. C. Schlea and D. H. Stoddard. Californium isotopes proposed for intracavitary and interstitial radiation therapy with neutrons. Nature 206, 1058-1059 (1965).
2. J. B. Knauer, Jr., C. W. Alexander and J. E. Bigelow. Cf-252 properties, production, source fabrication and procurement. Nucl. Sci. Appl. 2, 3-17 (1991).
3. D. H. Stoddard. Radiation Properties of Californium-252. Savannah River Laboratory Report DP-986. U. S. Department of Commerce. Springfield. VA. 1965.
4. 252Cf neutrons and assessed by histological tumour eradication. Br. J. Radiol. 63, 270-277 (1990).
5. 252Cf neutrons in preoperative bulky/barrel-cervix carcinoma radiotherapy. Int. J. Radiol. Oncol. Biol. Phys. 19, 1561-1568 (1990).
6. Y. Maruyama, M. Urano, J. Feola and J. G. Wierzbicki. Relative biological effectiveness for californium-252 neutron brachytherapy for bulky human carcinoma of the cervix. Endocuriether. Hyperthermia Oncol. 7, 125-129 (1991).
7. D. E. Lea and D. G. Cateheside. The mechanism of the induction of radiation of chromosome aberrations in tradeseantia. J. Genet. 44, 216-245 (1942).
8. A. M. Kellerer and H. H. Rossi. The theory of dual radiation action. Curr. Top. Radiat. Res. Q. 8, 85-158 (1972).
9. R. G. Dale and B. Jones. The assessment of RBE effects using the concept of biologically effective close. Int. J. Radiat. Oncol. Biol. Phys. 43, 639-645 (1999).
10. B. Jones and R. G. Dale. Estimation of optimum dose per fraction lor high LET radiations: Implications for proton radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 48, 1549-1557 (2000).
11. J. P. Slabbert, T. Theron, F. Zöller, C. Streffer and L. Bohm. A comparison of the potential therapeutic gain of p(66)/Be neutrons and d(14)/Be neutrons. Int. J. Radiat. Oncol. Biol. Phys. 47, 1059-1065 (2000).
12. M. Kubota, M. Suzuki, Y. Furnsawa, K. Ando, S. Koike, T. Kanai, F. Yatagai, M. Ohmura, H. Tatsuzaki and T. Inada. A comparison of biological effects of modulated carbon-ions and last neutrons in human osteosarcoma cells. Int. J. Radiat. Oncol. Biol. Phys. 33, 135-141 (1995).
13. 252Cf. Phys. Rev. C 22, 638-650 (1980).
14. 252Cf. Phys. Rev. C. 7, 1173-1185 (1973).
15. R). Publication 92. Annals of the ICRP. Pergamon Press, Oxford. 2003.
16. K. M. Vtyurin, V. N. Ivanov, V. S. Medvedev, G. F. Galantseva, S. A. Abdulkadyrov, L. F. Ivanova, G. A. Petrovskaya and V. I. Plichko. Californium-252 interstitial implants in carcinoma of the tongue. Int. J. Radiat. Oncol. Biol. Phys. 11, 441-449 (1985).
17. B. M. Vtyurin, V. S. Medvedev, V. N. Ivanov, V. A. Anikin and L. F. Ivanova. Perioperative neutron brachytherapy with californium-252. Int. J. Radiat. Oncol. Biol. Phys. 23, 873-879 (1992).
18. B. M. Vtyurin, V. S. Medvedev, V. A. Anikin, L. F. Ivanova, V. N. Ivanov, S. D. Fomin and A. A. Omarov. Neutron brachytherapy in the treatment of melanoma. Int. J. Radiat. Oncol. Biol. Phys. 28, 703-709 (1994).
19. E. Janulionis, V. Atkocius, J. G. Wierzbicki, K. Valuckas and Y. Kurtinaitis. Combined high dose rate californium-252 neutron brachytherapy and cobalt teletherapy for cervical cancer. Endocuriether. Hyperthemia Oncol. 12, 153-158 (1996).
20. L. A. Marjina, V. N. Kiseleva, M. I. Nechushkin, V. N. Cechonackij and G. P. Elisyutin. The results of treatment of patients with endometrial cancer and carcinoma cervix using californium-252 high-dose-rate. In Californium-252 Isotope for 21st Century Radiotherapy (J. G. Wierzbicki, Ed.). pp. 115-130. Kluwer. Dordrecht. The Netherlands. 1997.
21. V. O. Sidorchenkov, O. N. Denisenko, V. N. Ivanov and V. A. Kozlov. Intraeavitary neutron therapy for malignant rectal tumors using high activity Cf-252. In Californium-252 Isotope for 21st Century Radiotherapy (J. G. Wierzbicki, Ed.). pp. 179-198. Kluwer. Dordrecht. The Netherlands. 1997.
22. O. N. Denisenko, V. N. Ivanov, V. A. Kozlov, V. O. Sidorchenkov, A. A. Omarov, I. M. Chernichenko and V. N. Chekhonadsky. Dosimetry and treatment planning in high dose rate Cf-252 brachytherapy. In Californium-252 Isotope for 21st Century Radiotherapy (J. G. Wierzbicki, Ed.). pp. 221-232. Kluwer. Dordrecht. The Netherlands. 1997.
23. J. S. Rjabukin. Relative biological effectiveness of 252Cf. Med. Radiol. 30, 53-59 (1985). [in Russian]